BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 8.89% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.75% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 6.14% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 4.17% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.96% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Diagnostics & Research | 3.90% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.56% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.21% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.91% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.76% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.61% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 2.48% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 2.37% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 2.30% |
| TVTX | Travere Therapeutics Inc | Healthcare | Biotechnology | 2.27% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 2.23% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 2.16% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.11% |